Aims: To study circulating levels and distribution of adiponectin multimers wlow molecular weight (LMW)-, medium molecular weight (MMW)-and high molecular weight (HMW)-adiponectinx in preterm and full-term infants. Methods: Total serum adiponectin and its multimers were measured in 40 healthy infants at the age of one month and associations with anthropometric parameters wbody weight and length, body mass index (BMI)x, weight gain and metabolic indices (glucose, insulin) were examined. Twenty of the infants were born preterm (gestational age 33.2"1.6 weeks). Results: LMW-adiponectin level and its fractional ratio to total adiponectin were significantly higher in full-term than in preterm infants (P-0.001 and P-0.01, respectively), whereas, MMW-adiponectin level and its ratio were significantly lower (Ps0.03 and Ps0.01, respectively). HMW-adiponectin did not differ significantly between full-term and preterm infants and accounted for almost 60% of total adiponectin levels in both groups. HMW-adiponectin, but not MMW adiponectin or LMW adiponectin, correlated significantly with anthropometric measurements, similarly to total adiponectin; in addition, HMW adiponectin correlated significantly with weight gain.
Introduction
Adiponectin, an adipocytokine with profound insulin-sensitizing effects and important role in regulating systemic energy metabolism w15x, circulates in human blood as multimers with distinct molecular sizes: trimeric low molecular weight (LMW)-adiponectin, hexameric medium molecular weight (MMW)-adiponectin, and high molecular weight (HMW)-adiponectin w33x. It has been suggested that adiponectin complexes have different biological activities w23, 33x, but their specific properties are not yet fully understood. Studies in adults and obese children indicated that HMW-adiponectin is the major active form of this adipokine w2, 3, 9x.
A great body of evidence suggests that circulating levels of total adiponectin (composed of the sum of adiponectin complexes), are much higher in neonates and infants than levels in children and adults w16, 24x. Yet, numerous previous studies have documented positive correlations between total adiponectin levels and neonatal anthropometric indices w16, 24, 28, 30, 32x. Thus, it has been strongly suggested that adiponectin has a role in fetal and neonatal growth. However, the adiponectin complexes in neonates have not been studied extensively. Circulating HMW-adiponectin has been evaluated almost exclusively in cord blood of full-term newborns w10, 12, 13, 21x, whereas limited knowledge exists regarding MMW-adiponectin and LMW-adiponectin in either preterm or full-term infants w35x.
The aim of the present study was to determine the circulating concentrations and distribution of adiponectin complexes in preterm and full-term infants and to examine their possible associations with anthropometric parameters, weight gain and serum levels of glucose and insulin.
Materials and methods
The study population consisted of 40 healthy infants (20 fullterm and 20 preterm infants with similar gender distribution) who met the following criteria: (1) mothers with uncomplicated pregnancy (without gestational diabetes mellitus, thyroid disease, pregnancy-induced hypertension or autoimmune diseases) who had elected formula feeding, (2) no neonatal morbidity (without respiratory distress syndrome, hypotension, intraventricular hemorrhage, necrotizing enterocolitis, sepsis) or congenital malformation, and (3) tolerance of full enteral feeding the first day of life for full-term infants and up to the 7 th day of life for preterm infants. Gestational age was estimated from the last menstrual period and confirmed by fetal ultrasound measurements and clinical examination of the neonate according to the new Ballard score w4x.
Anthropometric measurements were recorded periodically in all the infants by the same investigator. In preterm infants, body weight was obtained daily using a standard electronic scale. Recumbent length and head circumference were measured weekly using a standardized length board and a non-stretchable plastic insertion tape, respectively. In full-term infants, body weight and length and head circumference were measured weekly by the same method applied to preterm infants. Weight gain in g/kg/day was estimated weekly in all infants. In addition, body weight Z-scores wstandard deviation (SD) scores from the mean after adjustment for gestational age and genderx were evaluated at the end of the first month of age as described previously w29x.
All infants underwent a venipuncture in the morning and before feeding at the end of the first month of age for collection of routine blood tests, as well as for determining total adiponectin and its multimers (HMW-, MMW-and LMW-adiponectin), glucose and insulin in serum.
The study protocol was approved by the Ethics Committee of ''Aghia Sophia'' Children's Hospital and informed parental consent was also obtained for all infants.
Total adiponectin, HMW-, MMW-, and LMW-adiponectin levels were determined by a sandwich enzyme-linked immunosorbent assay (ELISA) using a commercially available multimeric adiponectin kit (Buehlmann Laboratories AG, Switzerland, produced by Daiichi Pure Chemicals Co, Ltd, Tokyo, Japan). Details of the assay have been described previously w8x. The specific antibodies used in this kit were monoclonal anti-human adiponectin antibodies directed to two independent epitopes. For total adiponectin determination, specimens were treated with sodium dodecyl sulphate (SDS)-containing acid buffer to convert multimeric adiponectin to dimmeric and monomeric forms that were assayed directly on the plate. To measure the HMW-, MMW-, and LMW-adiponectin separately, samples were enzyme pretreated with two proteases, according to manufacturer instructions. For the HMW-adiponectin determination, protease II that selectively digests LMW-and MMW-adiponectin was used and the remaining HMW-adiponectin fraction was treated with SDScontaining acid buffer to convert it mainly to dimmeric and monomeric forms that were assayed directly on the plate w8x. Protease I that selectively digests only the LMW-adiponectin was used for MMWqHMW-adiponectin determination w8x. The concentrations of MMW-and LMW-adiponectin were obtained by subtracting the HMW concentration from the MMWqHMW concentrations and the MMWqHMW concentrations from the total adiponectin concentration, respectively. The intra-assay precision coefficients of variation (CVs) for total-, HMW-, and MMWqHMW-adiponectin were -5.4%, 5.0% and 5.0%, respectively, and the inter-assay CVs were -5.0%, 5.7% and 6%, respectively, at different adiponectin levels, according to the commercially available kit. The limit of sensitivity of the assay was -0.08 ng/mL. Serum glucose was assessed by an enzymatic glucose oxidase method and the determination was performed using the Siemens Advia 1800 Clinical Chemistry System (Siemens Healthcare Diagnostics, Erlangen, Germany). The intra-and inter-assay CVs were -0.9% and -1.5%, respectively. Serum insulin concentrations were assessed by an electrochemiluminesce immunoassay using the automated analyzer Cobas e 411 (Roche Diagnostics GmbH, Mannheim, Germany). This assay for insulin determination employs two monoclonal antibodies which together are specific for human insulin. The intra-and interassay CVs did not exceed 2% and 2.8%, respectively.
Data are presented as mean (SD), apart from insulin concentrations expressed as median (25 th -75 th percentiles) because of a non-normal distribution. Groups were compared for quantitative variables by the Student-t or Mann-Whitney U-test, as appropriate. Values of adiponectin multimers were normally distributed, both overall and for preterm and full-term infants separately. Correlation analyses were used to examine relations among the variables of interest. Statistical significance was set at P-0.05. All statistical analyses were performed using the SPSS statistical package (SPSS, version 12.0, Chicago, IL).
Results
Demographic characteristics, anthropometric and growth measurements of the study population are shown in Table 1 . Mean (SD) serum glucose concentrations were significantly higher in full-term w4.9 (0.6) mmol/Lx than in preterm infants w3.9 (0.8) mmol/L, P-0.01x. Median (25 th -75 th percentiles) insulin concentrations were also higher in full-term w6.9 (4.1-12.1) mU/Lx than in preterm infants w2.8 (1.2-15.2) mU/L, P-0.05x.
Serum levels of total-and LMW-adiponectin were significantly higher in full-term w46.6 (13.2) mg/mL and 11.7 (7.1) mg/mL, respectivelyx than in preterm infants w38.1 (11.2) mg/mL; Ps0.03 and 3.0 (2.5) mg/mL; P-0.001, respectivelyx, whereas, levels of MMW-adiponectin were lower w6.3 (4.5) mg/mL in full-term and 10.5 (7.4) mg/mL in preterm infants; Ps0.03x. No difference was found in HMW-adiponectin levels between full-term and preterm infants w28.9 (10.3) mg/mL and 25.0 (7.2) mg/mL, respectivelyx. In addition, the fractional HMW-adiponectin relative to total-adiponectin levels did not differ significantly between full-term and preterm infants (Figure 1 ). However, the ratio of MMW-adiponectin to total-adiponectin was lower in full-term than in preterm infants (Ps0.01), whereas the ratio of LMW-adiponectin to total adiponectin level was significantly higher (P-0.01) (Figure 1 ). There was no difference both in absolute values of adiponectin multimers and in their ratios to the total-adiponectin value between sexes in full-term and preterm infants. HMW-adiponectin levels correlated significantly with total-adiponectin levels in both full-term (rs0.87, 
Figure 1
Boxplots showing the fractional ratios of serum adiponectin multimers to total adiponectin in full-term (white boxes) and preterm infants (shaded boxes). Boxes represent the interquartile range; lines inside boxes represent the median value; whiskers represent the lowest and highest observations, respectively. Tstotal adiponectin, HsHMW-adiponectin, MsMMWadiponectin, LsLMW-adiponectin. P-0.001) and preterm infants (rs0.77, P-0.001). A significant correlation between MMW-adiponectin and totaladiponectin levels was observed in preterm infants only (rs0.93, P-0.001), whereas, LMW-adiponectin correlated significantly with total-adiponectin levels in full-term infants only (rs0.67, Ps0.001).
In the total study population, HMW-adiponectin levels correlated significantly with birth weight and anthropometric measurements when blood samples were drawn, including body weight, body weight Z-score and body mass index (BMI), similarly to total adiponectin (Table 2 ). In addition, HMW-adiponectin levels correlated significantly with the infants' weight gain, whereas, a non-significant correlation was recorded between total adiponectin and weight gain (Ps0.08). As shown in Table  2 , HMW-adiponectin presented all the significant associations observed between total adiponectin and variables studied in preterm and full-term infants separately. MMW-adiponectin and LMW-adiponectin did not correlate significantly with anthropometric measurements or weight gain in the total study population or in the groups of full-term and preterm infants. No significant correlation was also recorded between total adiponectin or any of the adiponectin complexes and glucose or insulin concentrations.
Discussion
According to the results of this study, there are some differences in level and distribution of adiponectin complexes between full-term and preterm infants. The circulating levels of MMW-adiponectin and their ratio to total-adiponectin levels were significantly lower in fullterm than in preterm infants, but levels of LMW-adiponectin and their proportion were higher. However, HMW-adiponectin levels did not differ significantly between full-term and preterm infants; they accounted for almost 60% of total-adiponectin levels in both groups. Total adiponectin levels were significantly lower in preterm than in full-term infants, in agreement with previous studies w28x; this difference was probably due to decreased adiposity of preterm infants. There is evidence that circulating adiponectin levels correlate positively with the degree of adiposity in neonates, but negatively in adults w16, 24, 32x. The daily intake of dietary longchain polyunsaturated fatty acids that might have influenced the total adiponectin levels w29x did not differ significantly between the two infant groups (data not shown). In addition, there was no difference in gender distribution between groups. A sex dimorphism in circulating adiponectin levels, with lower levels in males than females, has been described in adulthood w20x, in utero w6, 14x and in childhood, especially during the progression of puberty w1, 7, 22x, and has been attributed to direct or indirect effects of sex hormones on adiponectin secretion from adipocytes w1, 7, 11, 14, 20, 22x . However, gender differences in adiponectin levels were not present in several studies in neonates w10, 16, 24, 28, 32x and in our study as well.
To our knowledge, all the three forms of adiponectin multimers have been determined in both full-term and preterm infants only in the recent study of Yoshida et al. w35x . In that study, serum total adiponectin and its multimers were measured in 46 preterm infants at birth and at corrected term postmenstrual age, and in 26 full-term infants at birth w35x. Serum concentrations of total-, HMW-, MMW-, and LMW-adiponectin were significantly greater in full-term than preterm infants at birth, but similar to those of preterm infants at corrected term. The ratio of HMW-adiponectin to total-adiponectin was ;60% in full-term newborns, in agreement with our findings and with previous studies w12, 13, 21x. However, a direct comparison of the results of the study of Yoshida et al. w35x with ours cannot be done due to differences in study population, especially regarding the postnatal age and the anthropometric measurements of full-term infants.
It is difficult to explain the meaning of the observed differences in levels and proportions of MMW-and LMWadiponectin between preterm and full-term infants. It has been shown that the distribution of adiponectin multimers is influenced by environmental factors, such as acidic conditions and concentrations of calcium, glucose, and testosterone w5, 27, 34x, as well as genetic factors, such as mutations of adiponectin associated with impaired multimerization w33x. Adiponectin multimer composition is affected by alterations in posttranslational modifications of adiponectin in response to environmental factors during its production and/or secretion by adipose tissue w25, 26x. However, once synthesized and secreted, the adiponectin multimers circulate as biochemically distinct and stable entities with little evidence of interchange between the different forms w27x. In our view, it would be interesting to ascertain whether the pattern of adiponectin multimer distribution observed in preterm infants reflects a particular distribution of adiponectin multimers in fetal life before term and/or is related to differences in subcutaneous or brown adipose tissue between full-term and preterm infants w31x.
The physiological role of human adiponectin multimers is of special interest. In previous studies in adults and obese children, HMW-adiponectin has been reported to correlate inversely with anthropometric measurements (body weight or BMI, waist girth, visceral adipose tissue), metabolic parameters (insulin and homeostasis model of assessment of insulin resistance) and the development of the metabolic syndrome better than plasma total adiponectin levels w2, 9, 17x. In contrast, weak or absent correlations between MMW-or LMW-adiponectin and the above-mentioned parameters have been reported w18, 19x. Thus, the effects of the MMW-and LMW-adiponectin are still unclear, whereas HMW-adiponectin is believed to be the primary active form having similar biological roles to those recognized, so far, for total adiponectin w2, 3, 9, 19x. In previous studies of HMWadiponectin in cord blood, it has been suggested that HMW-adiponectin has a role on fetal or neonatal growth because it correlated positively with neonatal anthropometric parameters w12, 13x.
In our study, HMW-adiponectin did not correlate with metabolic parameters (glucose, insulin), contrary to previous studies in older children and adults w2, 9, 17x but in accordance with other studies in neonates w12, 32x. HMW-adiponectin was the only multimer of adiponectin exerting significant associations with the infants' anthropometric measurements and growth rates and the one that correlated with the variables that total adiponectin was associated with. Further studies are needed to elucidate if HMW-adiponectin is indeed the active form of adiponectin and to evaluate the biological role of MMWand LMW-adiponectin multimers in preterm and full-term infants.
